Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Debt Instrument, Increase, Accrued Interest

2.8 / 5 stars · 68/120 Roast Me

ADMA BIOLOGICS, INC. Debt Instrument, Increase, Accrued Interest

ADMA BIOLOGICS, INC. (ADMA) reported Debt Instrument, Increase, Accrued Interest of $0 for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-10.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2016-11-10

  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for the quarter ending 2016-09-30 was $0.00.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for the quarter ending 2016-03-31 was $0.00.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for the quarter ending 2015-12-31 was $0.00.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for fiscal 2015 was $105.66K.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for fiscal 2014 was -$69.07K.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for fiscal 2013 was -$36.60K.
  • ADMA BIOLOGICS, INC. debt instrument, increase, accrued interest for fiscal 2012 was $0.00.
Period endDebt Instrument, Increase, Accrued Interest 3 monthDebt Instrument, Increase, Accrued Interest 3 month as first filedDebt Instrument, Increase, Accrued Interest 6 monthDebt Instrument, Increase, Accrued Interest 6 month as first filedDebt Instrument, Increase, Accrued Interest 9 monthDebt Instrument, Increase, Accrued Interest 9 month as first filedDebt Instrument, Increase, Accrued Interest 12 monthDebt Instrument, Increase, Accrued Interest 12 month as first filed
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$0.00
derived: sum of 2 quarters · filed 2016-11-10
$0.00
10-Q · filed 2016-11-10
$0.00
derived: sum of 4 quarters · filed 2016-11-10
2016-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
$0.00
10-Q · filed 2016-08-12
$0.00
derived: sum of 3 quarters · filed 2016-08-12
$0.00
derived: sum of 4 quarters · filed 2016-11-10
2016-03-31$0.00
10-Q · filed 2016-05-13
$0.00
derived: sum of 2 quarters · filed 2016-05-13
$0.00
derived: sum of 3 quarters · filed 2016-11-10
$114.72K
derived: sum of 4 quarters · filed 2016-11-10
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23
$0.00
derived: sum of 2 quarters · filed 2016-11-10
$114.72K
derived: sum of 3 quarters · filed 2016-11-10
$105.66K
10-K · filed 2016-03-23
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
$114.72K
derived: sum of 2 quarters · filed 2016-11-10
$105.66K
10-Q · filed 2016-11-10
$73.67K
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$114.72K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
$105.66K
10-Q · filed 2016-08-12
$73.67K
derived: sum of 3 quarters · filed 2016-08-12
$73.30K
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31-$9.05K
10-Q · filed 2016-05-13
$9.05K
10-Q · filed 2015-05-12
-$41.05K
derived: sum of 2 quarters · filed 2016-05-13
-$41.41K
derived: sum of 3 quarters · filed 2016-05-13
-$123.12K
derived: sum of 4 quarters · filed 2016-05-13
2014-12-31-$32.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23
-$32.36K
derived: sum of 2 quarters · filed 2016-03-23
-$114.07K
derived: sum of 3 quarters · filed 2016-03-23
-$69.07K
10-K · filed 2016-03-23
2014-09-30-$365.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
-$82.07K
derived: sum of 2 quarters · filed 2015-11-10
-$37.07K
10-Q · filed 2015-11-10
$37.07K
10-Q · filed 2014-11-10
-$109.08K
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30-$81.70K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11
-$36.70K
10-Q · filed 2015-08-11
$36.70K
10-Q · filed 2014-08-11
-$108.72K
derived: sum of 3 quarters · filed 2015-08-11
-$108.72K
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$45.00K
10-Q · filed 2015-05-12
-$27.01K
derived: sum of 2 quarters · filed 2015-05-12
-$27.01K
derived: sum of 3 quarters · filed 2015-05-12
-$24.89K
derived: sum of 4 quarters · filed 2015-05-12
2013-12-31-$72.01K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
-$72.01K
derived: sum of 2 quarters · filed 2015-03-09
-$69.89K
derived: sum of 3 quarters · filed 2015-03-09
-$36.60K
10-K · filed 2015-03-09
$36.60K
10-K · filed 2014-03-28
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$2.13K
derived: sum of 2 quarters · filed 2014-11-10
$35.42K
10-Q · filed 2014-11-10
$33.46K
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30$2.13K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$35.42K
10-Q · filed 2014-08-11
$33.46K
derived: sum of 3 quarters · filed 2014-08-11
$33.46K
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$33.29K
10-Q · filed 2014-05-12
$31.33K
derived: sum of 2 quarters · filed 2014-05-12
$31.33K
derived: sum of 3 quarters · filed 2014-05-12
$31.33K
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31-$1.96K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
-$1.96K
derived: sum of 2 quarters · filed 2014-03-28
-$1.96K
derived: sum of 3 quarters · filed 2014-03-28
$0.00
10-K · filed 2014-03-28
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$0.00
derived: sum of 2 quarters · filed 2013-11-12
$1.96K
10-Q · filed 2013-11-12
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12
$1.96K
10-Q · filed 2013-08-12
2012-03-31$1.96K
10-Q · filed 2013-05-14
2011-09-30$210.09K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13
$398.63K
derived: sum of 2 quarters · filed 2012-11-13
$575.17K
10-Q · filed 2012-11-13
2011-06-30$188.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14
$365.08K
10-Q · filed 2012-08-14
2011-03-31$176.55K
10-Q · filed 2012-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43